RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Zimovetz, E., Beard, S., Hodgkins, P., Bischof, M., Mauskopf, J., & Setyawan, J. (2013). Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom. Value in Health, 16(7), A549-A549.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.

Meet the Experts

Navigate to Josephine A. Mauskopf

Josephine A. Mauskopf

Recent Publications

Article

Developing capacity in identifying cost-effective interventions to prevent and reduce obesity in China
Article

US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines
Article

Comparing youth-friendly clinics to the standard of care for adolescent girls and young women in Malawi: A qualitative analysis
Article

Patient-reported outcome improvements following scalp hair regrowth among patients with Alopecia Areata: analysis of the ALLEGRO-2b/3 trial